Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of HybridAPC for Gastric Mucosal Ablation in the Management of Patients With Class III Obesity

NCT05574777 is registered in ClinicalTrials.gov with Erbe Elektromedizin GmbH as lead sponsor.

NCT NCT05574777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05574777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of HybridAPC for Gastric Mucosal Ablation in the Management of Patients With Class III Obesity
Lead sponsor
Erbe Elektromedizin GmbH
Phase
Not applicable
Overall status
Completed
Start date
April 13, 2023
Completion date
March 30, 2026
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adiposity, morbid, obesity